Search

everythinglearnresearchcommunity

for

Search:↓

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

PRP is an effective and safe treatment for female hair loss.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Non-drug therapies show promise for hair regrowth but need more research.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.